Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin in advanced prostate cancer
NCT00002723Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1996
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised trial of suramin in prostate cancer (PCa) (3 arms), sponsored by National Cancer Institute. Primary endpoint: Response Rate. Started Jan 1996; status: completed.
02
Drugs
suramin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00002723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002723.